I think that fear was some of the reason ACHN came down so much this week
I don't see the GDP number impacting a spec stock like this. Especially after it has sold off so much.
Throw in a 2.9 million float.
It would be so easy for momo traders to push this to 9
"Gilead is trying to get treatment time down to six weeks or less, from 12 weeks or more offered by current drugs. Experts say it won’t be easy". The best way for them to do that is buy ACHN